Shareholders' Inquiry Transfer Plan
Filed with SSE · · 5 pages · Chinese
Summary by 6ix AI
The plan involves the transfer of a specific number of shares, which represents a small percentage of the company's total equity. The transfer will not occur through public trading methods and has specific conditions for the participating institutional investors. The company assures that there are no undisclosed risks or changes in control related to this transfer.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai InnoStar Bio-tech Co. Ltd. on 6ix
Earlier from Shanghai InnoStar Bio-tech
- Special Report on Deposit, Management and Actual Use of Raised Funds in 2025
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Result of Shareholding Reduction by Shareholders
- Announcement on Change of the Signing Accountant
- Announcement on Earnings Preannouncement for 2025
Later from Shanghai InnoStar Bio-tech
- Indicative Announcement on Pricing for Shareholders' Inquiry-based Transfer
- Indicative Announcement on Report on Results of Shareholders' Inquiry-based Transfer and Share Reduction of Shareholders with Over 5% Shares to Less than 5%
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Resignation of Chairman and Directors, Election of Chairman and Directors, and Adjustment of Members of the Special Committee under the Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Shanghai InnoStar Bio-tech into a list and get an email when it puts out news.
Follow Shanghai InnoStar Bio-tech